Recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 13–15 November 2016
Ahmed N., Steiner T., Caso V., Wahlgren N., Tatlisumak T., Lundström E., Debette S., Markus H., Engelter ST., Arnold M., Bornstein N., Cooray C., Paciaroni M., Bulbulia R., Mattle H., Berge E., Prazeres Moreira T., Ntaios G., Charidimou A., Ford GA., Lantz M., Sjoöstrand C., Christensen H., Steinberg A., Tomson T., Holtkamp M., Cordonnier C., Lees KR., Eriksson E., Norrving B., Veltkamp R., Dichgans M., Kostulas K., Robinson T., Hacke W., Russell D., Thorén M., Ringleb P., Söderman M., Markaki I., Brainin M., Leys D., Fischer U., Mazya M., Andersen G., Damgaard D., Davalos A.
© 2017, © European Stroke Organisation 2017. About the meeting: The purpose of the European Stroke Organisation (ESO)-Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an opportunity for the participants to discuss how these results may be implemented into clinical routine. Several scientific sessions discussed in the meeting and each session produced consensus statements. The meeting started 20 years ago as Karolinska Stroke Update, but since 2014, it is a joint conference with ESO. Importantly, it provides a platform for discussion on the ESO guidelines process and on recommendations to the ESO guidelines committee on specific topics. By this, it adds a direct influence from stroke professionals otherwise not involved in committees and work groups on the guidelines procedure. The discussions at the conference may also inspire new guidelines when motivated. The topics raised at the meeting are selected by the scientific programme committee mainly based on recent important scientific publications. The ESO-Karolinska Stroke Update consensus statement and recommendations will be published every 2 years and it will work as implementation of ESO-guidelines Background: This year’s ESO-Karolinska Stroke Update Meeting was held in Stockholm on 13–15 November 2016. There were 10 scientific sessions discussed in the meeting and each session produced a consensus statement (Full version with background, issues, conclusions and references are published as web-material and at http://www.eso-karolinska.org/2016 and http://eso-stroke.org) and recommendations which were prepared by a writing committee consisting of session chair(s), secretary and speakers and presented to the 312 participants of the meeting. In the open meeting, general participants commented on the consensus statement and recommendations and the final document were adjusted based on the discussion from the general participants. Recommendations (grade of evidence) were graded according to the 1998 Karolinska Stroke Update meeting with regard to the strength of evidence. Grade A Evidence: Strong support from randomised controlled trials and statistical reviews (at least one randomised controlled trial plus one statistical review). Grade B Evidence: Support from randomised controlled trials and statistical reviews (one randomised controlled trial or one statistical review). Grade C Evidence: No reasonable support from randomised controlled trials, recommendations based on small randomised and/or non-randomised controlled trials evidence.